Scientist, Analytical Method Development

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

The Role

The Analytical Method Development (AMD) team is part of Analytical Development within CMC Product Development. The team develops biochemical and molecular assays that support manufacturing process development, pilot-scale manufacturing, and future quality control activities at designated GMP sites.

As a Scientist in AMD, you will develop and qualify analytical assays supporting the manufacturing and future release of antibody-based therapeutics. Working closely with scientists and Research Associates, you will combine hands-on assay development with scientific oversight and project coordination for programs entering early-stage CMC development.

You will guide Research Associates in their daily work and scientific decision-making, helping translate analytical questions into well-designed studies and meaningful results. In collaboration with colleagues across Analytical Development, CMC Product Development, and other key functions, you will ensure that studies are scientifically robust, meet applicable regulatory requirements, and maintain data integrity. You will also contribute to improving analytical capabilities that support the development of the next generation of antibody therapeutics.

This is a temporary position for 12 months, covering a colleague’s leave of absence . While an extension is not currently anticipated, any continuation beyond the initial 12-month period would depend on the department’s needs and the availability of new regular roles.

Are you interested in developing your skills and gaining valuable experience within an international biotech company? We look forward to receiving your CV and motivation letter!

Responsibilities

• Serve as the subject matter expert for capillary electrophoresis techniques, including CE-SDS and icIEF, analytical chromatography such as HPLC, and absorbance spectroscopy.

• Provide scientific oversight of assay development, qualification, and transfer in accordance with ICH guidelines.

• Collaborate with internal stakeholders, including project managers, Drug Substance Product Development, Drug Product Development, and Operations, and external partners such as CMOs and CROs to deliver high-quality data, assays, and reports.

• Review and interpret complex analytical data, translating findings into clear conclusions, recommendations, technical reports, protocols, and regulatory-supporting documentation.

• Plan and prioritize work packages within cross-functional teams to meet project deliverables.

• Proactively identify opportunities to improve method robustness, efficiency, data quality, and scientific relevance while supporting continuous improvement of team processes.

Requirements

• A completed PhD in biochemistry, protein chemistry, analytical sciences, or another relevant scientific discipline, or an MSc with at least two years of relevant experience.

• Relevant experience in protein analysis, preferably supporting the development or manufacturing of antibodies or other therapeutic proteins within a CMC environment.

• Experience with biochemical analytical techniques, with practical experience in CE-SDS, icIEF, HPLC, and absorbance spectroscopy.

• Familiarity with binding assays and technologies such as ELISA, Octet, or surface plasmon resonance (SPR) would be advantageous.

• Experience with statistical analysis using tools such as JMP or GraphPad, knowledge of ICH Q2/Q14 guidelines, and experience developing assays using analytical Quality by Design (aQbD) principles would be advantageous.

• The ability to manage multiple priorities, communicate effectively with internal and external stakeholders, and deliver high-quality scientific work within agreed timelines.

• An interest in software, automation, digitalization, and analytical data handling and trending.

• A collaborative approach, with motivation to support the development of others and continuously improve analytical workflows and team capabilities.

• As this is a temporary position, you must already be based in the Netherlands at the time of application. Relocation support is not available for this role.

Intended recruitment timeline

• Application deadline: Thursday, 8 October 2026, end of day.

• Shortlisting: Week of 12 October 2026.

• Virtual screenings: Week of 19 October 2026.

• Onsite interviews: From 26 October till 6 November 2026.

• Intended start date: 1 January 2027.

The proposed gross annual/monthly base salary range for this position, in the primary location, based on a full time schedule is:

EUR58.000,00---87.000,00


The final salary offer will depend on several factors, including your skills, qualifications, and experience.

In addition to base salary, this position is eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives.

When you join Genmab, you become a part of a culture that supports your physical, financial, social, and emotional well-being. Our benefits include, but are not limited to:

• Pension
• Health insurance and wellness benefits
• Paid time off
• Employee support programs

Further details on eligibility for compensation and benefits based on the role will be provided during the recruitment process.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X .

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com) .

Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the contract.